Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

Subjects:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Subjects:

Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

Subjects:

Graphical presentation of % decrease for insulin from baseline at different conditions. by Nathan Mubiru (21627195)

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Animal studies demonstrated that inotodiol possessed the ability to suppress tumor growth in nude mice models, at the same time, there was no significant impact on the body weight and organs of the mice. …”

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. by Ana M. Sandoval-Castellanos (11611315)

“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”

Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023. by Yan Wang (15435)

Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. by Yasuyuki Sotani (20114144)

Subjects:

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)